Aducanumab and the amyloid beta hypothesis is not dead yet!
|
1
|
BIOASIS TECHNOLOGIES INC
|
Oct 22, 2019 09:09AM
|
Re: Resverlogix H2 2018 events
|
1
|
Resverlogix Corp.
|
Nov 09, 2018 11:59AM
|
Re: Presentations-FYI...
|
1
|
Resverlogix Corp.
|
Jan 09, 2018 12:14PM
|
Resverlogix Announces 3-Month Loan Extension
|
1
|
Resverlogix Corp.
|
May 02, 2019 09:46PM
|
ZZXY
|
1
|
Zenith Epigenetics
|
May 13, 2018 08:13PM
|
Re: BiOasis Enters into a License Agreement with Astellas Research Institute
|
1
|
BIOASIS TECHNOLOGIES INC
|
Apr 21, 2016 10:30PM
|
Re: Resverlogix Confirms Significant Corporate Advancement Establishing Apabetalone as Potential Blockbuster Combo Drug in High-risk Diabetics with CVD
|
1
|
Resverlogix Corp.
|
Jan 13, 2020 09:20AM
|
Re: Resverlogix Provides Groundbreaking Results...
|
1
|
Resverlogix Corp.
|
Jan 23, 2017 11:22AM
|
Re: AHA 2018
|
1
|
Resverlogix Corp.
|
Nov 09, 2018 12:43PM
|
Re: New analyst?
|
1
|
BIOASIS TECHNOLOGIES INC
|
Sep 26, 2020 12:24PM
|
Re: Data-Lock,...
|
1
|
Resverlogix Corp.
|
May 31, 2019 02:09PM
|
Apabetalone mention in new article on evolving lipid lowering therapies
|
1
|
Resverlogix Corp.
|
Feb 02, 2018 11:17AM
|
Re: Zenith/JNJ
|
1
|
Zenith Epigenetics
|
Aug 27, 2018 05:53PM
|
Re: Presentations-FYI...
|
1
|
Resverlogix Corp.
|
Jan 09, 2018 12:45PM
|
Re: AGM Notice
|
1
|
Resverlogix Corp.
|
Nov 03, 2016 04:21PM
|
Re: My one-minute commercial for Apabetalone
|
1
|
Resverlogix Corp.
|
Sep 11, 2019 06:39AM
|
Re: Webcast is up
|
1
|
Resverlogix Corp.
|
Nov 01, 2019 11:51AM
|
Zenith website undergoing changes
|
1
|
Zenith Epigenetics
|
Feb 23, 2016 12:22PM
|
Re: Resverlogix Announces Publication on Apabetalone in Clinical Epigenetics
|
1
|
Resverlogix Corp.
|
Jul 15, 2019 10:38AM
|
Re: Prosperous New Year?
|
1
|
BIOASIS TECHNOLOGIES INC
|
Aug 26, 2016 11:49AM
|